88 results found

In a world where the challenges of neuropsychiatric disorders, epilepsy, and chronic pain persist, a remarkable biotechnology company, Bright Minds Biosciences Inc., is embarking on a mission to provide hope to patients grappling with these conditions. With an impressive portfolio of next-generation serotonin agonists, the company is resolute in targeting th...

Recently, the intriguing prospect of psychedelic mushrooms as a remedy for depression has generated significant interest. This unconventional approach to addressing one of the most prevalent mental health disorders globally has piqued the curiosity of researchers, healthcare practitioners, and individuals seeking innovative alternatives for managing their em...

The human brain is a marvel of complexity, responsible for our thoughts, emotions, and actions. Yet, it is not immune to disorders that can have profound effects on an individual's life. From neurodevelopmental conditions like autism to neurodegenerative diseases such as Alzheimer's, the impact of brain disorders can be far-reaching. In this blog, we will ex...

Serotonin is a crucial neurotransmitter that regulates various physiological functions in the human body, including mood, sleep, and appetite. It is often referred to as the "feel-good" neurotransmitter, as it is associated with feelings of happiness and well-being. In this article, we will explore the importance of serotonin and discuss the optimal serotoni...

Mental health disorders affect millions of people worldwide, and the demand for effective treatments is higher than ever. Historically, drug development in the field of mental health has faced numerous challenges due to the complexity of these conditions and the subjective nature of their assessment. However, the integration of digital health technologies ha...

Bright Minds Biosciences has completed its Phase I first-in-human study of BMB-101 being developed for the treatment of refractory epilepsies, psychosis, addiction, and impulse control disorders. The three-part study assessed the pharmacokinetic (PK), tolerability, safety, and food effect of the 5-HT2C agonist BMB-101 in healthy volunteers.

In today's fast-paced world, stress has become an unwelcome companion in many of our lives. The demands of work, family, and daily life can easily overwhelm us, taking a toll on our mental and physical health. However, there are effective stress management techniques that can help us regain control, reduce stress, and promote our overall well-being. In this ...

Neuropsychiatric disorders encompass a wide range of conditions affecting the brain and mind, including depression, anxiety disorders, bipolar disorder, schizophrenia, and neurodevelopmental disorders like autism and ADHD. These conditions not only affect the individuals who experience them but also have a profound impact on their families. In this article, ...

In recent years, the psychedelics industry has emerged as a promising sector for investors seeking opportunities in the rapidly expanding field of mental health and wellness. Canada, known for its progressive stance on cannabis legalization, is at the forefront of the psychedelic revolution. Today, we will delve into some of the key Canadian psychedelic comp...

For centuries, human beings have sought altered states of consciousness through various means, from meditation and fasting to dance rituals and ingestion of mind-altering substances. One class of substances that has captured the imagination of scientists, artists, and spiritual seekers alike are psychedelics. Psychedelics, such as LSD, psilocybin, and DMT, h...

Psychedelic substances, once associated with counterculture movements and recreational use, are now gaining recognition for their transformative potential in the realm of mental health treatment. Ongoing research into compounds like psilocybin (found in magic mushrooms) and MDMA (commonly known as ecstasy) is revealing promising results for the treatment of ...

In recent years, psychedelic drugs have garnered significant attention, both for their potential therapeutic benefits and the legal and ethical dilemmas they pose. Psychedelics, such as psilocybin (magic mushrooms), LSD (lysergic acid diethylamide), and MDMA (3,4-methylenedioxymethamphetamine), have a long history of human use, often associated with spiritua...